Novartis Ag
General ticker "NVSEF" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $201.6B
Novartis Ag follows the US Stock Market performance with the rate: 16.5%.
Estimated limits based on current volatility of 1.1%: low 95.28$, high 97.42$
Factors to consider:
- Company pays dividends: last record date 2024-03-07, amount 3.74$ (Y15.30%)
- Current price 12.1% above estimated high
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [62.92$, 88.61$]
- 2023-12-31 to 2024-12-30 estimated range: [60.93$, 87.28$]
Financial Metrics affecting the NVSEF estimates:
- Positive: Non-GAAP EPS, $ of 6.12 > 2.29
- Negative: Industry operating cash flow per share per price (median), % of -15.82 <= 3.85
- Positive: Inventory ratio change, % of 0.97 <= 1.08
- Positive: 7.18 < Operating cash flow per share per price, % of 7.37
- Negative: Industry inventory ratio change (median), % of 3.13 > 0.49
Short-term NVSEF quotes
Long-term NVSEF plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $49,898.00MM | $52,877.00MM | $51,828.00MM |
| Operating Expenses | $39,746.00MM | $41,188.00MM | $42,631.00MM |
| Operating Income | $10,152.00MM | $11,689.00MM | $9,197.00MM |
| Non-Operating Income | $-274.00MM | $14,448.00MM | $-826.00MM |
| Interest Expense | $869.00MM | $811.00MM | $837.00MM |
| R&D Expense | $8,980.00MM | $9,540.00MM | $9,996.00MM |
| Income(Loss) | $9,878.00MM | $26,137.00MM | $8,371.00MM |
| Taxes | $1,806.00MM | $2,116.00MM | $1,416.00MM |
| Profit(Loss) | $8,072.00MM | $24,021.00MM | $6,955.00MM |
| Stockholders Equity | $56,598.00MM | $67,655.00MM | $59,342.00MM |
| Inventory | $7,131.00MM | $6,666.00MM | $7,175.00MM |
| Assets | $132,059.00MM | $131,795.00MM | $117,453.00MM |
| Operating Cash Flow | $13,650.00MM | $15,071.00MM | $14,236.00MM |
| Capital expenditure | $2,585.00MM | $2,971.00MM | $2,671.00MM |
| Investing Cash Flow | $-13,182.00MM | $4,208.00MM | $1,468.00MM |
| Financing Cash Flow | $-2,208.00MM | $-16,264.00MM | $-20,562.00MM |
| Earnings Per Share* | $3.76 | $10.73 | $3.29 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.